MPR Weekly Dose Podcast: Episode 10

This week we talk about the resurrection of Biogen’s novel Alzheimer treatment; A “landmark” approval in cystic fibrosis; Expanded indication for Farxiga; The first topical minocycline formulation for acne vulgaris; and the Johnson & Johnson baby powder recall.

MPR Weekly Dose Podcast: Episode 9

This week we talk about new treatment approvals for acute migraine, dry eye disease and schizophrenia; a new indication for Xarelto; and the CDC issue an interim guidance for physicians regarding electronic cigarette, or vaping, product use-associated lung injury, or ‘EVALI’.

MPR Weekly Dose Podcast: Episode 6

This week: A new type 2 diabetes treatment in tablet form; Pancreatitis treatment gains Orphan Drug status; New approval for smallpox, monkeypox; An investigational treatment for Guillain-Barré Syndrome; and big changes at e-cigarette maker, Juul.

MPR Weekly Dose Podcast: Episode 2

This week: New draft guidelines for Lyme Disease management; First-in-class antibiotic to treat community-acquired bacterial pneumonia; Duchenne muscular dystrophy drug denied; Approval for a rheumatoid arthritis treatment; and the FDA make a decision on Hetlioz for jet lag disorder.